001     639214
005     20251014215458.0
024 7 _ |a 10.1016/j.sbi.2025.103165
|2 doi
024 7 _ |a 0959-440X
|2 ISSN
024 7 _ |a 1879-033X
|2 ISSN
024 7 _ |a 10.3204/PUBDB-2025-04336
|2 datacite_doi
037 _ _ |a PUBDB-2025-04336
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Genz, Luca
|0 P:(DE-H253)PIP1097784
|b 0
245 _ _ |a Drug targeting of protein-nucleic acid interactions
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1760447374_2867353
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a and DFG CRC1648
520 _ _ |a Protein–nucleic acid interactions are vital to gene regulation and disease, yet have long been considered “undruggable.” Recent advances are reshaping this paradigm, enabling therapeutic targeting of DNA- and RNA-binding proteins. In this review, we highlight four major strategies: (1) direct disruption of protein-nucleic acid binding, (2) stabilization of specific complexes or conformations, (3) targeted degradation of interaction partners, and (4) allosteric modulation. We explore key examples across transcription factors, RNA-binding proteins, and DNA repair proteins, and emphasize emerging chemical, structural, and computational techniques that are accelerating discovery. Together, by intervening directly in the gene regulatory machinery, these approaches expand the druggable genome and open new avenues for treating cancer, genetic disorders, and viral infections.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |0 EXP:(DE-MLZ)NOSPEC-20140101
|5 EXP:(DE-MLZ)NOSPEC-20140101
|e No specific instrument
|x 0
700 1 _ |a Nair, Sanjana
|0 P:(DE-H253)PIP1101921
|b 1
700 1 _ |a Sweeney, Aaron
|0 P:(DE-H253)PIP1100083
|b 2
700 1 _ |a Topf, Maya
|0 P:(DE-H253)PIP1094132
|b 3
|e Corresponding author
773 _ _ |a 10.1016/j.sbi.2025.103165
|g Vol. 95, p. 103165 -
|0 PERI:(DE-600)2019233-2
|p 103165
|t Current opinion in structural biology
|v 95
|y 2025
|x 0959-440X
856 4 _ |y OpenAccess
|u https://bib-pubdb1.desy.de/record/639214/files/1-s2.0-S0959440X25001836-main.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://bib-pubdb1.desy.de/record/639214/files/1-s2.0-S0959440X25001836-main.pdf?subformat=pdfa
909 C O |o oai:bib-pubdb1.desy.de:639214
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 0
|6 P:(DE-H253)PIP1097784
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-H253)PIP1097784
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 1
|6 P:(DE-H253)PIP1101921
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 2
|6 P:(DE-H253)PIP1100083
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 3
|6 P:(DE-H253)PIP1094132
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-H253)PIP1094132
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-09
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR OPIN STRUC BIOL : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-09
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-09
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR OPIN STRUC BIOL : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-09
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-09
920 1 _ |0 I:(DE-H253)CSSB-LIV_UKE-MT-20220525
|k CSSB-LIV/UKE-MT
|l CSSB - Leibniz-Institut für Experimentelle Virologie (LIV) / UKE - Maya Topf
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)CSSB-LIV_UKE-MT-20220525
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21